Skip to main content

Carbetapentane / Diphenhydramine Side Effects

Applies to carbetapentane/diphenhydramine: oral suspension extended release.

General adverse events

General side effects have included excessive perspiration, chills, and dryness of mouth, nose and throat.[Ref]

Hematologic

Hematologic side effects have included hemolytic anemia, thrombocytopenia, and agranulocytosis.[Ref]

Nervous system

Nervous system side effects have included sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesia, vertigo, acute labyrinthitis, tinnitus, and convulsions.[Ref]

Ocular

Ocular side effects have included blurred vision and diplopia.[Ref]

Gastrointestinal

Gastrointestinal side effects have included epigastric distress, anorexia, nausea, vomiting, diarrhea, and constipation.[Ref]

Genitourinary

Genitourinary side effects have included urinary frequency, difficult urination, urinary retention, and early menses.[Ref]

Respiratory

Respiratory side effects have included thickening of bronchial secretions, tightness of chest or throat, wheezing, and nasal stuffiness.[Ref]

Hypersensitivity

Hypersensitivity side effects have included urticaria, drug rash, anaphylactic shock, and photosensitivity.[Ref]

Cardiovascular

Cardiovascular side effects have included hypotension, headache, palpitations, tachycardia, and extrasystoles.[Ref]

References

1. (2006) "Product Information. Dytan-AT (carbetapentane-diphenhydramine)." Hawthorn Pharmaceuticals

Further information

Carbetapentane/diphenhydramine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.